Table 1.
Patient characteristics: overall and stratified by disease
| All (N = 402) |
Patients with asthma (N = 196) |
Patients with COPD (N = 206) |
p | |
|---|---|---|---|---|
| Male (%) | 50.5 | 39.8 | 60.7 | <.01 |
| Age (years) (M; SD) | 56.7 (15.9) | 47.7 (16.7) | 65.3 (8.85) | <.01 |
| Migrational background (%) | 6.0 | 7.1 | 5.0 | .36 |
| Living alone (%) | 19.3 | 16.3 | 22.3 | .13 |
| Schooling | <.01 | |||
| < 10 years (%) | 57.5 | 40.3 | 74.4 | |
| 10 years (%) | 26.7 | 33.0 | 20.5 | |
| ≥ 10 years (%) | 15.8 | 26.7 | 5.1 | |
| Age at diagnosis (years) (M; SD) | 46.7 (17.8) | 36.4 (18.3) | 56.6 (10.1) | <.01 |
| Duration of disease (years) (M; SD) | 9.9 (9.1) | 11.5 (9.9) | 8.4 (7.9) | <.01 |
| Inpatient treatment (%) | 37.8 | 4.6 | 69.4 | <.01 |
| Time needed to visit provider of asthma/COPD treatment (min) (M; SD) | 27.2 (17.6) | 24.2 (16.7) | 30 (18.0) | <.01 |
| Number of visits to the provider of asthma/COPD treatment during the last year (M; SD) | 4.7 (5.2) | 3.0 (2.4) | 6.3 (6.5) | <.01 |
| Disease severity/control | n.a. | |||
| CAT score | – | – | 23.2 (7.2) | |
| ACQ score | – | 1.5 (1.2) | – | |
| Experience of severe side effects (% yes) | 16.4 | 8.3 | 24.2 | <.01 |
| Number of prescribed medicines (M; SD) | 4.8 (3.9) | 2.7 (2.3) | 6.9 (4.0) | <.01 |
| Number of prescribed inhalers (M; SD) | 1.9 (0.9) | 1.7 (0.9) | 2.1 (1.0) | <.01 |
| Number of prescribed pills (M; SD) | 2.7 (3.5) | 0.8 (1.9) | 4.5 (3.6) | <.01 |
| Number of other prescribed medicines (M; SD) | 0.2 (0.6) | 0.1 (0.4) | 0.4 (0.7) | <.01 |
| SF-12 PCS (M; SD) | 39.0 (12.6) | 46.5 (10.8) | 31.8 (9.7) | <.01 |
| SF-12 MCS (M; SD) | 40.9 (13.7) | 44.0 (12.4) | 38.0 (14.3) | <.01 |
| GSE (M; SD) | 24.4 (6.0) | 30.7 (5.0) | 28.2 (6.6) | <.01 |
| HADS-depression (M; SD) | 6.7 (4.7) | 5.2 (4.1) | 8.3 (4.6) | <.01 |
| HADS-anxiety(M; SD) | 7.8 (4.3) | 7.4 (4.2) | 8.1 (4.3) | .10 |
| BMQ- overuse (M; SD) | 3.1 (0.7) | 3.1 (0.7) | 3.2 (0.7) | .68 |
| BMQ- harm (M; SD) | 2.4 (0.7) | 2.4 (0.6) | 2.5 (0.7) | .15 |
| BMQ- utility (M; SD) | 3.9 (0.7) | 3.9 (0.6) | 3.9 (0.7) | .61 |
| BMQ- concerns (M; SD) | 2.4 (0.8) | 2.2 (0.7) | 2.6 (0.8) | <.01 |
| BMQ- necessity (M; SD) | 3.8 (0.9) | 3.5 (1.0) | 4.1 (0.7) | <.01 |
Group differences were analysed using χ2 or t tests
CAT COPD assessment test, ACQ Asthma Control Questionnaire, SF-12 PCS Physical Component Scale, SF-12 MCS Mental Component Scale, GSE Generalized Self-Efficacy Scale, HADS Hospital Anxiety and Depression Scale, BMQ Beliefs about Medicines-Questionnaire